Actively Recruiting

Age: 18Years - 55Years
All Genders
ID06275230

Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in Chronic Obstructive Pulmonary Disease

Led by China-Japan Friendship Hospital · Updated on 2025-02-10

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the ability to grow human lung stem cells in the lab and create lung organoids derived from patients with Chronic Obstructive Pulmonary Disease (COPD). The study aims to answer whether human lung stem cells can multiply in vitro and if lung organoids from COPD patients can be successfully established. Participants will be sampled during a pulmonary bronchoscopy procedure. Participants in this observational study are patients with COPD who will undergo bronchoscopy to collect samples for lung stem cell and organoid research. There are no experimental treatments or drugs being given, as the study focuses on sample collection during standard medical procedures. During the study, participants will have the number of patients completing bronchoscopy recorded as the main outcome measure. The study involves a single day of bronchoscopy sampling, with no additional interventions or long-term follow-up specified. Researchers will monitor the success of lung stem cell proliferation and organoid construction from the collected samples.

CONDITIONS

Brief Title

Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age under 55, regardless of gender
  • Patients with COPD lung disease who are going to undergo bronchoscopic biopsy
  • No genetic diseases and other respiratory diseases
Not Eligible

You will not qualify if you...

  • Conditions making sampling or follow-up difficult
  • Presence of other serious diseases
  • Other conditions deemed unsuitable by investigators for inclusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants with COPD undergo bronchoscopic biopsy to collect lung samples.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China, 100029

Actively Recruiting

Loading map...

Research Team

M

Mingming Deng, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Vascular Function in Health and Disease: Rehabilitation for ...

Chronic Obstructive Pulmonary Disease

Actively Recruiting

1 location

Efficacy and Safety of Inhaled Nitric Oxide for Moderate-to-...

Chronic Obstructive Pulmonary Disease

Actively Recruiting

1 location

Phase I Clinical Study to Evaluate the Safety, Tolerability ...

Chronic Obstructive Pulmonary Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here